[Process in development of PTH, an awaited bone-density conservation agent].
Toshitsugu
T
Sugimoto
D000818:Animals; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D007279:Injections, Subcutaneous; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D058866:Osteoporotic Fractures / Q000209:etiology / Q000517:prevention & control; D019379:Teriparatide / Q000008:administration & dosage* / Q000009:adverse effects
D050071:Bone Density Conservation Agents; D019379:Teriparatide